The new SureSeq myPanel NGS Custom Cancer Panel provides scientists with completely customized, pre-optimized next-generation sequencing (NGS) probe panels relevant to their research. The comprehensive library of gene content covers key cancer types, including myeloid, chronic lymphocytic leukemia, ovarian and breast. The panels provide uniform coverage through all target regions, including intronic and splice sites, and reduce the need for fill-in Sanger sequencing.

 

As new probes are added, these panels can be replaced or added to at a much lower cost compared to fixed panels.